Top Federal Drug Official Touts Therapeutic ‘Promise’ Of Psychedelics And
A top federal health official is again touting the therapeutic “promise” of psychedelics such as psilocybin and MDMA—though she says the drugs’ Schedule I status remains a research barrier to scientifically validating their efficacy. In a blog post this month, National Institution on Drug Abuse (NIDA) Director Nora Volkow said the “potential use of psychedelics…
Top Federal Drug Official Touts Therapeutic ‘Promise’ Of Psychedelics And Read More »










